Metabolic Dysfunction-Associated Steatohepatitis

Disease State Hub

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

Featured

Pop Quiz
physician with chart talking to patient
Pop Quiz
Understanding the “Big 4” Drivers of Cardiometabolic Risk
04/06/2026
Anthony Calabro, MA
Test your knowledge of the four interrelated conditions driving cardiometabolic risk and how early intervention can alter disease progression.
04/06/2026
Expert Q&A
Anum Saeed MD
Expert Q&A
The “Big 4” of Cardiometabolic Risk: A Call for Early, Multidisciplinary Management
03/06/2026
Anum Saeed, MD
In this Q&A, Anum Saeed, MD discusses how cardiologists must think beyond LDL and blood pressure, leveraging GLP-1 receptor agonists, SGLT-2 inhibitors, and emerging therapies to reduce cardiovascular...
03/06/2026
Quiz Series
physician taking a quiz
Quiz Series
Advancing Clinical Understanding of MASH from Disease Biology to Therapeutic Targets
11/10/2025
Anthony Calabro, MA
With the approval of resmetirom and GLP-1 receptor agonists showing promise as a potential treatment option, the management of metabolic dysfunction-associated steatohepatitis (MASH) is rapidly evolving....
11/10/2025

Interactive Features

Pop Quiz
physician with chart talking to patient
Pop Quiz
Understanding the “Big 4” Drivers of Cardiometabolic Risk
04/06/2026
Anthony Calabro, MA
Test your knowledge of the four interrelated conditions driving cardiometabolic risk and how early intervention can alter disease progression.
04/06/2026
Quiz Series
physician taking a quiz
Quiz Series
Advancing Clinical Understanding of MASH from Disease Biology to Therapeutic Targets
11/10/2025
Anthony Calabro, MA
With the approval of resmetirom and GLP-1 receptor agonists showing promise as a potential treatment option, the management of metabolic dysfunction-associated steatohepatitis (MASH) is rapidly evolving....
11/10/2025
Quiz Series
doctor pointing to liver
Quiz Series
What Do You Know About MASH?
08/22/2025
Anthony Calabro, MA
Metabolic dysfunction–associated steatohepatitis is becoming increasingly common in patients with type 2 diabetes and other metabolic risk factors. Test your knowledge of the key diagnostic features,...
08/22/2025
Pop Quiz
Liver
Pop Quiz
Prevalence of NASH
03/10/2023
Test your knowledge on the prevalence of nonalcoholic steatohepatitis in the United States by taking our short pop quiz!
03/10/2023
POLL
POLL
Targeting Liver Treatments
03/01/2023
Individuals with MASH and significant liver fibrosis have a higher risk for serious liver-related outcomes compared with those with simple steatosis. Which endpoint should be a target for treatment: MASH...
03/01/2023

Clinical Insights

Expert Q&A
Anum Saeed MD
Expert Q&A
The “Big 4” of Cardiometabolic Risk: A Call for Early, Multidisciplinary Management
03/06/2026
Anum Saeed, MD
In this Q&A, Anum Saeed, MD discusses how cardiologists must think beyond LDL and blood pressure, leveraging GLP-1 receptor agonists, SGLT-2 inhibitors, and emerging therapies to reduce cardiovascular...
03/06/2026
Roundtable
Naim Alkhouri MD
Roundtable
Initiating Resmetirom for Patients With MASH: Recommendations on Patient Selection, Treatment Response, and Patient Monitoring
07/19/2025
Naim Alkhouri, MD; Amreen M. Dinani, MD, FRCPC; Mazen Noureddin, MD, MHSc
In this video, Naim Alkhouri MD, FAASLD moderates a roundtable discussion with Amreen M. Dinani, MD, FRCPC and Mazen Noureddin, MD, MHSc on the practical clinical applications associated with starting and...
07/19/2025
ROUNDTABLE
James Matera DO
ROUNDTABLE
Key Updates on the Treatment and Management of MASH
10/08/2024
James Matera, DO
In this video, James Matera, DO moderates a roundtable discussion with Colin Brown, MD, Kunal Gupta MD, and Lisa Jones, MA, RD that reviews the recent developments regarding the treatment and management of...
10/08/2024
Video
Naim Alkhouri, MD
Video
The Relationship Between Waist Circumference, Liver Disease
03/07/2024
In this video, Dr Alkhouri discusses the relationship between waist circumference and metabolic dysfunction-associated steatotic liver disease (MASLD)/metabolic dysfunction-associated steatohepatitis,...
03/07/2024
Guest Commentary
Guest Commentary
Noninvasive Point-of-Care Examinations for Liver Disease can Enhance Patient Engagement, Improve Outcomes
05/04/2023
In this commentary, Robert G. Gish, MD, from the Hepatitis B Foundation, writes about the importance of early detection, prevention, and treatment of liver disease, as well as the role of physicians at...
05/04/2023